Swetha Kambhampati

Assistant Professor at City of Hope; Alum: UCSF heme/onc, Hopkins IM, Stanford Med; Interested in lymphoma and CART

[Swetha Kambhampati @SwethaKMD]

I got my ARB losses back. @dom_dillionz @praween_nusrat @IsmayaRania @KeerthiGeeth @seriouscawcaw @SadracChora @mazharkazmi123 @Blessroth

[Swetha Kambhampati @SwethaKMD]

Im SHIB for always @nunez_julian @hex_xyiv @karshaleos @Crofwgkta @rost_1989 @diazruben16sj @MUSICSAOLOR @vinccirom

[Swetha Kambhampati @SwethaKMD]

SHIB for life @KazeemKhaled @186 @ZakaCrypto @devanpr03 @JosephDShook @Div_R2022 @an49787142 @SuyatnoJayadin2 @unyil0109

[Swetha Kambhampati @SwethaKMD]

Chilling with my ARB reimbursement money @Irmatralala_ @Abdulaz84267922 @michael27677957 @MindySpurlock1 @T1_034 @Nino369Nino369 @HoaTrongTuyt1 @Moneymagnet84

[Swetha Kambhampati @SwethaKMD]

Im SHIB for always @Nidhi90868859 @allwar71 @Emerald09918692 @LLove6688 @mimi_VOD @AxSidh @pjmlantunes @TheFreedomProt1

[Swetha Kambhampati @SwethaKMD]

I just went into beta its so FIRE @GLC_Inc_ @SamuelP40277471 @ConnieG168 @ClemonTinnel @Hutchin95272841 @SosoMauro @kisaan5556678 @0xmengzi

[Swetha Kambhampati @SwethaKMD]

LFG! @Jc0x01 @HjuGaa @Alicia91830639 @monkedegen @alex_osec @Pawel75591576 @8ergej @atom8088

[Swetha Kambhampati @SwethaKMD]

When's public ARB @maron_MaHaLo @EvanANorman @Homelander144 @ThnhNgu02050662 @dung_nhan_vao @nachampn @elekxmiki @minisatthu @kinobe_ @Kriptoagatmi

[City of Hope @cityofhope]

Developing the treatments of tomorrow is hard work. @DoctorAKrishnan, M.D., and @elizabeth_budde, M.D., Ph.D., are leading a few clinical trials related to bispecific antibodies and their ability to target cancer cells more precisely than chemo. https://t.co/to7k4B0llm #HemOnc

[Blood Cancers Today @Blood_Cancers]

Axicabtagene ciloleucel showed a significant improvement in OS over standard of care in patients with relapsed or refractory LBCL, according to the primary OS analysis of the phase III ZUMA-7 study released by @KitePharma.
https://t.co/a2fNzHfAnP

[Blood Cancers Today @Blood_Cancers]

🔊OUT NOW: This all-new episode of The HemOnc Pulse features host @chadinabhan speaking with @SwethaKMD of @cityofhope and Nikhil Thiruvengadam, MD, about the cost effectiveness of pola-R-CHP in relation to other therapies for DLBCL.
@SocietyofHemOnc
https://t.co/2QLZHdUKO8

[Swetha Kambhampati @SwethaKMD]

I got my Shib Yards @OlegDCH @Iura57163635 @CherkutP @HuongNt40173119 @Dim4err_ @413647746Peter @mohammedhafida1 @NdkhoaE

[Jason Westin, MD FACP FASCO @Lymphoma_Doc]

Huge news! ZUMA-7 trial shows axi-cel improves overall survival in patients with second-line aggressive lymphoma, compared to chemo/autoSCT. Statistically significant, which should end the “try chemo first” argument. Full data to be presented in the next few months. #lymsm

[Jorge Cortes MD @jorgecortesmd]

Dr. Ayushi Chauhan @Chauhan_AF from @GACancerCenter named the 2023 Stephanie A. Gregory Distinguished Scholar by the Lymphoma Research Foundation @lymphoma. A brilliant young investigator. Very proud of her accomplishments.

[Swetha Kambhampati @SwethaKMD]

@GCC_Cortes @Chauhan_AF @GACancerCenter @lymphoma Congratulations!!!

[Swetha Kambhampati @SwethaKMD]

@Chauhan_AF @WomenInLymphoma Thank you so much!

[Swetha Kambhampati @SwethaKMD]

@RahulBanerjeeMD Thank you so much!

[Blood Cancers Today @Blood_Cancers]

🔊Coming Thursday, 3/23: An all-new episode of The HemOnc Pulse features host @chadinabhan speaking with @SwethaKMD of @cityofhope and Nikhil Thiruvengadam, MD, of @UCSF about modeling the cost effectiveness of pola-R-CHP in relation to other DLBCL therapies.
@SocietyofHemOnc

[Colton Ladbury, MD @ColtonLadbury]

Excited the City of Hope experience with bridging therapy prior to CAR T for LBCL is published. Thanks for the collaboration between @COH_RadOnc and @COHMedOnc. Stay tuned for our prospective trial shortly! https://t.co/2NYWPJkBpb

[Swetha Kambhampati @SwethaKMD]

Phenomenal and inspirational week at LRF LSRMP! great mentorship and developed life long friendships and connections! Grateful for the experience @lymphoma @cityofhope

[Timothy Voorhees, MD, MSCR @tvoorheesmd]

Amazing week with LRF LSRMP at Lake Las Vegas. Great protocol development. Meeting mentors and colleagues was invaluable! @lymphoma @OSUHematology